Publications

Publications

Article
Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Maeda M, Murata F, Fukuda H.
Bivalent vaccine effectiveness among older adults aged ≥65 years during the BA.5 predominant period in Japan: the VENUS Study.
Open Forum Infectious Diseases 2023; 10(10): ofad475.
Graphical Abstract
Tsuzuki S, Murata F, Maeda M, Asai Y, Koizumi R, Ohmagari N, Fukuda H.
The association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015-2016 to 2020-2021 seasons: from the VENUS study.
Journal of Antimicrobial Chemotherapy 2023; 78(12): 2976-2982.
Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H.
Effectiveness of COVID-19 Vaccines against Infection in Japan: A Test-Negative Study from the VENUS Study.
Vaccine 2023; 41(37): 5447-5453.
Graphical Abstract
Maeda M, Murata F, Fukuda H.
Effect of COVID-19 Vaccination on Household Transmission of SARS-CoV-2 in the Omicron Era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
International Journal of Infectious Diseases 2023; 134: 200-206.
Graphical Abstract
Ishiguro C, Mimura W, Uemura Y, Maeda M, Murata F, Fukuda H.
Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
Open Forum Infectious Diseases 2023; 10(7): ofad274
Fukuda H, Maeda M, Murata F.
Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS Study.
Vaccine 2023; 41(23): 3556-3563.
Graphical Abstract
Narii N, Kitamura T, Komukai S, Zha L, Komatsu M, Murata F, Maeda M, Kiyohara K, Sobue T, Fukuda H.
Association of pneumococcal vaccination with cardiovascular diseases in older adults: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study.
Vaccine 2023; 41(13): 2307-2313.
Graphical Abstract
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods in Japan: The VENUS Study.
Open Forum Infectious Diseases 2022; 9(12): ofac636.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
International Journal of Infectious Disease 2022;125: 58-60
Ishiguro C, Mimura W, Murata F, Fukuda H.
Development and Application of a Japanese Vaccine Database for Comparative Assessments in the Post-Authorization Phase: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study.
Vaccine 2022; 40(42): 6179-6186.
1 2 3 4
× Graphical Abstract